Navigation Links
New tool to predict the risk of death in COPD may help physicians to individualize treatment
Date:8/28/2009

Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. The study of the ADO index is published in the August 29 edition of the Lancet.

Currently, the BODE index is used by chest physicians to estimate a patient's risk of death from COPD. The index is based on an assessment of body-mass index, airflow obstruction, dyspnea and exercise capacity. However, the BODE index is rarely used in primary care settings where most patient treatment options are managed, because exercise capacity cannot be easily measured in the typical doctor's office.

"The burden from COPD is so enormous that we need to reach out to any doctors who care for COPD patients. The ADO index can be used in any setting and we hope that it will serve as a basis for more individualized treatment selection in the near future," said Milo A. Puhan, MD, PhD, associate professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health and lead author of the study.

For the study, Puhan and colleagues developed a simplified BODE index and the ADO index, which included age, dyspnea and airflow obstruction. The research team compared the predictions of the BODE index with the 3-year risk of all-cause mortality from 232 COPD patients from Switzerland. The updated BODE index and the new ADO index were then validated with a cohort of 342 COPD patients from Spain.

According to the study, the updated BODE and ADO indices accurately predicted 3-year mortality and matched the observed mortality in the Spanish cohort well with little difference between predicted and observed mortality com
'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gene assay to help to predict lung cancer treatment resistance
2. New study suggests the brain predicts what eyes in motion will see
3. Glucose Challenge in Pregnancy Could Predict Heart Disease
4. New Omega-3 Blood Test: A Better Predictor of Coronary Heart Disease Than Cholesterol
5. Pain Level May Predict Survival in Certain Cancer Patients
6. New biomarker predicts response to hepatitis C treatment
7. NIAID media availability: Still searching for predictors of asthma attacks
8. Predictors of disease behavior change in Crohn’s disease
9. Great Lakes' New Digital Splints Offer Accuracy, Predictable Results, and Reduced Chair-time
10. Immunoglobulin Can Predict Some Diabetic Complications
11. Sex Hormone Protein May Predict Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...hysician-scientists from Weill Cornell Medical Col...y prove to be a powerful target for the treatment ...ffects lymphocytes, or white blood cells. By explo...o powerfully suppress tumor formation in lab testi...e led to the design of a clinical trial that will ...
(Date:11/22/2009)...& Machine post You Tube video demonstrating th... Landover, MD (PRWEB) Novemb...in learning what a really rugged waterproof keyboa...ool Keyboard vs Washable Competitors Keyboard HD&r...ow the premium, Really Cool Keyboard from Man &am...
(Date:11/21/2009)... Milvia Lopez, by her attorney MICH...led suit, in Supreme Court, New York County, beari... while Ms. Lopez underwent a routine transesophage...AL , doctors used an HIV infected scope exposing h...ral hours after being discharged from the procedur...
(Date:11/21/2009)...vative medical apparel company launches men,s lab ... San Clemente, Calif. (PRWEB) November 21,...cal apparel, today announced the launch of its men... a leading international trade fair for the medica...naugurates its men,s collection with three varying...
(Date:11/20/2009)...ist Closer to Understanding Brain Wiring and Disea...re/ -- Dr. Jeremy Schmahmann, Professor of Neurolo...e Massachusetts General Hospital in Boston, on Thu...earch on the new field of study called "Connectivi..., Dr. Schmahmann is an award-winning leader in the...
Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...ory for patient-centered medical home model, WASH... Collaborative (PCPCC) released the following stat...e bill, which includes a provision,for a $100 mill... medical home demonstration projects in Medicare w...
... 10 Omnicell, Inc.,(Nasdaq: OMCL ), a leading pr...ilities, will hold a conference call Monday, July ...nancial results., What: Omnicell second quart... Rob Seim, chief financial officer Where: ...
...fect developing brain,s ability to make neural con...News) -- Common underlying mechanisms that affect ...gly disparate gene mutations found in autistic peo...ople that appear to be tied to inherited mutations...
...mproves Kidney Care in America--Increased,Kidney C...fit, WASHINGTON, July 10 In response to the,pass...dney Care Partners,(KCP) -- an alliance of patient...nd kidney failure -- applauded the United,States S...
...wing is a,statement by Mark J. Feldman, DMD, Presi...ncement that 70 percent of the U.S. population now...me this very encouraging news from the Centers for...and,scientific study that community water fluorida...
...prove Genetic Healthcare and Educate Patients, SA... and,Iverson Genetic Diagnostics, Inc. today annou...personalized reports for individuals receiving,Ive... for Iverson customers, allowing physicians who wo...
Other Medicine News:Health News:Omnicell to Release Second Quarter 2008 Earnings Results on July 21 2Health News:Common Mechanisms May Contribute to Autism's Mutations 2Health News:Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 3
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-F...q: BCRX ) today announced the pricing of a public...at $9.75 per share, resulting in gross proceeds of...red by BioCryst pursuant to an effective shelf reg...rities and Exchange Commission. BioCryst has also...
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswir...aq: ALXA ) announced today that its corporate pre...ual Piper Jaffray Health Care Conference on Wednes...The presentation will be webcast from The New York... Thomas B. King, Alexza President and CEO. ,,...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Binghamton Research Group Develops New Cancer Treatment 5010 1Binghamton Research Group Develops New Cancer Treatment 5010 2Binghamton Research Group Develops New Cancer Treatment 5010 3Binghamton Research Group Develops New Cancer Treatment 5010 4HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1Reactive oxygens role in metastasis 9946 1Reactive oxygens role in metastasis 9946 2
...ta Selected and Presented as,Platform Presentation...Technology,Demonstrates Optimal Functional Activit...-- Discovery,Laboratories, Inc. (Nasdaq:DSCO) anno...hase 2 clinical trial of Surfaxin(r),(lucinactant ...reatment of Bronchopulmonary Dysplasia (BPD) were ...
...May 8, 2007 - King,Pharmaceuticals, Inc. (NYSE:KG)... clinical trial for its ALTACE(R) (ramipril),diure...merican,Society of Hypertension,s Twenty-Second An...ay 19, 2007 at the Hyatt Regency Hotel,Chicago, I... for,review from 10 AM to 6 PM CDT. The Company pr...
Other Medicine Technology:Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 2Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 3Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 4Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 5Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 6Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 7King Pharmaceuticals Announces Plan to Present Results from Phase,III Clinical Trial Evaluating ALTACE as Monotherapy and in,Combination with Hydrochlorothiazide at the American Society of,Hypertension Annual Meeting 2
...n advanced scientific formulation that provides po...ct Plus is based on the AREDS clinical trial, and ...g the role of lutein in eye health. Featuring low ...nt blend of antioxidant nutrients and delivers 15 ...
...is a scientifically advanced nutritional formulati...nd full body health. MacularProtect Complete is ba... research. It features a comprehensive multinutrie...ntioxidants, such as 10 mg of FloraGLO® lutein...
Oculair
Ocuvite® Eye Vitamins and Mineral Supplement
Medicine Products: